A COMPARATIVE STUDY IN TWO DIFFERENT SCALE OF HOMOEOPATHIC MEDICINE IN THE TREATMENT OF MOLLUSCUM CONTAGIOSUM.
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/04/051295
- Lead Sponsor
- PRATAP CHANDRA MEMORIAL HOMOEOPATHIC HOSPITAL AND COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.CLINICALLY DIAGNOSED CASES OF MOLLUSCUM CONTAGIOSUM
2.LITERATE PATIENTS ABLE TO READ PATIENT INFORMATION SHEET
3.PARENTS PROVIDING WRITTEN INFORMED CONSENT TO PARTICIPATE
Exclusion Criteria
1. IF PATIENT HAVING ANY OTHER SKIN DISEASES ALONG WITH MOLLUSCUM CONTAGIOSUM
2.PATIENTS HAVE UNDERGONE ORGAN TRANSPLANTATION
3.PATIENTS USING IMMUNOSUPPRESIVE MEDICATION
4.PATIENTS USING STEROIDS
5.CASES ALREADY UNDERGOING HOMOEOPATHIC TREATMENT FOR ANY CHRONIC PURPOSE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.TO EVALUATE THE IMPROVEMENT OF MOLLUSCUM CONTAGIOSUM PATIENT TREATED BY INDIVIDUALISED HOMOEOPATHIC APPROACH BY USING TWO DIFFERENT POTENCY SCALES <br/ ><br>2.TO EVALUATE THE ROLE OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN IMPROVEMENT OF QUALITY OF LIFE USING DERMATOLOGY LIFE QUALITY INDEX (DLQI) IN BOTH THE SCALES <br/ ><br>3.COMPARE THE IMPROVEMENT IN BOTH 50-MILLESIMAL AND CENTISIMAL SCALESTimepoint: BASELINE AND THREE MONTHS
- Secondary Outcome Measures
Name Time Method DLQI SCALETimepoint: BASELINE AND SIX MONTHS